ReviewAntibody therapeutics2022

Strategies to mitigate the on- and off-target toxicities of recombinant immunotoxins: an antibody engineering perspective.

Mengyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.